TREM2 and Alzheimer disease: In the early stages of AD, TREM2 knockdown reduced the secretion of cytokines and other inflammatory markers in 35 different transgenic mouse models, while its knockdown from microglia in later stages induced neuroinflammation by increasing the secretion of proinflammatory cytokines [128].